US 11377447
Targeted therapeutics
granted A61KA61K31/4745A61K47/10
Quick answer
US patent 11377447 (Targeted therapeutics) held by Madrigal Pharmaceuticals, Inc. expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/4745, A61K47/10, A61K47/55, A61K9/0019